Home/ID4Pharma/James J-H Lee, PhD
JJ

James J-H Lee, PhD

CEO, Principal Investigator

ID4Pharma

Therapeutic Areas

ID4Pharma Pipeline

DrugIndicationPhase
Sequesta™Multiple MyelomaPre-clinical